Effect of Hydroxychloroquine on the Annexin A5 Resistance Assay in Antiphospholipid Antibody-Positive Patients With and Without Systemic Lupus Erythematosus.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Hydroxychloroquine (Primary)
- Indications Antiphospholipid syndrome; Systemic lupus erythematosus
- Focus Pharmacodynamics
- 27 Mar 2017 Biomarkers information updated
- 25 Nov 2011 New trial record